Overview
Formerly MAPS Public Benefit Corporation, Lykos Therapeutics is advancing MDMA-assisted therapy for PTSD through Phase 3 clinical trials and FDA regulatory review. They are a pioneer in the clinical development of psychedelic-assisted psychotherapy.
More in Psychedelics
Latest industry news
Precision Neuroscience Raises $250M to Accelerate Brain-Computer Interface Development
2026-11-01 · Funding
Merge Labs Gets Competition as New Rival Neurotech Startup Enters the Consumer BCI Arena
2026-10-31 · Industry
Neuralink Connects to Grok AI Agent, Enabling ALS Patient to Control AI and Make Calls by Thought Alone
2026-10-30 · Product
Implanted BCIs Still Lack a Shared Safety Rulebook, and the Field Is Running Out of Time to Write One
2026-10-29 · Research
Company details
Category
🍄 Psychedelics
Location
San Jose, CA, USA
Funding
Non-profit/PBC · Grant-funded
Website
lykostherapeutics.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →